Bakker, Lytske
Aarts, Jos
Uyl-de Groot, Carin
Redekop, Ken
Funding for this research was provided by:
Horizon 2020 Framework Programme (644906)
Article History
Received: 8 July 2021
Accepted: 1 November 2021
First Online: 29 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: CUG reports unrestricted grants from Boehringer Ingelheim, Celgene, Janssen-Cilag, Genzyme, Astellas, Sanofi, Roche, Astra Zeneca, Amgen, Gilead, Merck, Bayer, outside the submitted work. The remaining authors have no competing interest to declare.